Evidence map›Paper›PMID 33945510›Full record

ArticleThe Journal of clinical investigation2021

Huntington's disease mice and human brain tissue exhibit increased G3BP1 granules and TDP43 mislocalization.

Isabella I Sanchez, Thai B Nguyen, Whitney E England, Ryan G Lim, Anthony Q Vu, Ricardo Miramontes, Lauren M Byrne, Sebastian Markmiller, Alice L Lau, Iliana Orellana and 8 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 2 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 2 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. The Role of Stress Granules in Cardiovascular Diseases.Reviews in cardiovascular medicine · 2026
    Review
  5. ALS and Huntington Disease: Unraveling the Connections between TDP-43 and Huntingtin.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Review
  6. Review
  7. Article
  8. Genetic therapies for neurological diseases.Pharmacological reviews · 2026
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. mEMBO reports · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 4 countries.

Isabella I SanchezDepartment of Neurobiology & Behavior.
Thai B NguyenDepartment of Neurobiology & Behavior.
Whitney E EnglandDepartment of Pharmaceutical Sciences, and.
Ryan G LimInstitute for Memory Impairment and Neurological Disorders, University of California, Irvine, California, USA.
Anthony Q VuDepartment of Cellular and Molecular Medicine, and.
Ricardo MiramontesInstitute for Memory Impairment and Neurological Disorders, University of California, Irvine, California, USA.
Lauren M ByrneUCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, United Kingdom.
Sebastian MarkmillerDepartment of Cellular and Molecular Medicine, and.
Alice L LauDepartment of Psychiatry & Human Behavior, and.
Iliana OrellanaSue and Bill Gross Stem Cell Center, University of California, Irvine, California, USA.
Maurice A CurtisDepartment of Anatomy and Medical Imaging, Faculty of Medical and Health Science, and.
Richard Lewis Maxwell FaullDepartment of Anatomy and Medical Imaging, Faculty of Medical and Health Science, and.
Gene W YeoDepartment of Cellular and Molecular Medicine, and.
Christie D FowlerDepartment of Neurobiology & Behavior.
Jack C ReidlingInstitute for Memory Impairment and Neurological Disorders, University of California, Irvine, California, USA.
Edward J WildUCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, United Kingdom.
Robert C SpitaleDepartment of Pharmaceutical Sciences, and.
Leslie M ThompsonDepartment of Neurobiology & Behavior.
University of California, Irvine · USUniversity of California San Diego · USHuntington's Disease Association · GBUniversity of Auckland · NZPharmaceutical Biotechnology (Czechia) · CZ

Funding

Functional RNA elements in the human genomeR01HG004659 · NHGRI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Kevin Daniel Corbett, Eugene Wei-Ming Yeo · 2008 to 2026
$12.4M
Molecular Mechanisms of Pathogenesis in Huntington’s diseaseR35NS116872 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI Leslie Michels Thompson · 2020 to 2026
$8.5M
Project 3: TRiC modulation of CNS pathogenesis in HD mouse modelsP01NS092525 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI THOMPSON, LESLIE MICHELS · 2016 to 2020
$6.3M
Epigenetic Pathology and Therapy in Huntington's DiseaseR01NS089076 · NINDS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI FRAENKEL, ERNEST, HOUSMAN, DAVID · 2015 to 2024
$4.9M
NRSA Training CoreTL1TR001415 · NCATS · UNIVERSITY OF CALIFORNIA-IRVINE · PI CAIOZZO, VINCENT JAMES, HEAD, ELIZABETH · 2015 to 2023
$4.2M
Training Program in Stem Cell Translational Medicine for Neurological DisordersT32NS082174 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI PETER John DONOVAN, Leslie Michels Thompson · 2013 to 2026
$3.3M
Epitranscriptomic mechanisms of fear-related learning and memoryR01MH109588 · NIMH · UNIVERSITY OF CALIFORNIA-IRVINE · PI SPITALE, ROBERT C · 2016 to 2020
$1.9M
Medical Research Council MR/M008592/1NCATS NIH HHS TL1 TR001415NHGRI NIH HHS R01 HG004659NIMH NIH HHS R01 MH109588NINDS NIH HHS P01 NS092525NINDS NIH HHS R01 NS089076NINDS NIH HHS R35 NS116872NINDS NIH HHS T32 NS082174
6 · The paper itself

Abstract

Chronic cellular stress associated with neurodegenerative disease can result in the persistence of stress granule (SG) structures, membraneless organelles that form in response to cellular stress. In Huntington's disease (HD), chronic expression of mutant huntingtin generates various forms of cellular stress, including activation of the unfolded protein response and oxidative stress. However, it has yet to be determined whether SGs are a feature of HD neuropathology. We examined the miRNA composition of extracellular vesicles (EVs) present in the cerebrospinal fluid (CSF) of patients with HD and show that a subset of their target mRNAs were differentially expressed in the prefrontal cortex. Of these targets, SG components were enriched, including the SG-nucleating Ras GTPase-activating protein-binding protein 1 (G3BP1). We investigated localization and levels of G3BP1 and found a significant increase in the density of G3BP1-positive granules in the cortex and hippocampus of R6/2 transgenic mice and in the superior frontal cortex of the brains of patients with HD. Intriguingly, we also observed that the SG-associated TAR DNA-binding protein 43 (TDP43), a nuclear RNA/DNA binding protein, was mislocalized to the cytoplasm of G3BP1 granule-positive HD cortical neurons. These findings suggest that G3BP1 SG dynamics may play a role in the pathophysiology of HD.

Indexed as

AnimalsCytoplasmic GranulesDNA-Binding ProteinsDNA HelicasesFemaleHippocampusHumansHuntington DiseaseMaleMiceMicroRNAsNeuronsPoly-ADP-Ribose Binding ProteinsPrefrontal CortexProtein TransportRNA HelicasesDNA-Binding ProteinsDNA HelicasesG3BP1 protein, humanG3bp1 protein, mouseMicroRNAsPoly-ADP-Ribose Binding ProteinsRNA HelicasesRNA Recognition Motif ProteinsTARDBP protein, humanNeurodegenerationNeuroscience

Identifiers

PMID33945510
PMCPMC8203471
OpenAlexW3157116735

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.